Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,6 USD | -1,84% | -7,51% | +3,23% |
Omzet 2024 * | 94,02 mln. 87,59 mln. | Omzet 2025 * | 72,9 mln. 67,91 mln. | Marktkapitalisatie | 108 mln. 101 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -24 mln. -22,36 mln. | Nettowinst (verlies) 2025 * | -43 mln. -40,06 mln. | EV/omzet 2024 * | 1,15 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1,49 x |
K/w-verhouding 2024 * |
-5,52
x | K/w-verhouding 2025 * |
-4,23
x | Werknemers | 121 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,81% |
Recentste transcriptie over CytomX Therapeutics, Inc.
1 dag | -1,84% | ||
1 week | -7,51% | ||
Lopende maand | -26,61% | ||
1 maand | -25,23% | ||
3 maanden | +4,58% | ||
6 maanden | +36,75% | ||
Lopend jaar | +3,23% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sean McCarthy
CEO | Chief Executive Officer | 57 | 01-12-10 |
Chris Ogden
DFI | Director of Finance/CFO | 40 | 02-08-21 |
Marcia Belvin
CTO | Chief Tech/Sci/R&D Officer | 57 | 01-01-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Meyers
BRD | Director/Board Member | 58 | 20-12-18 |
Elaine Jones
BRD | Director/Board Member | 69 | 01-12-14 |
Sean McCarthy
CEO | Chief Executive Officer | 57 | 01-12-10 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 1,6 | -1,84% | 286 317 |
24-04-24 | 1,63 | -2,98% | 350 911 |
23-04-24 | 1,68 | +0,60% | 290 181 |
22-04-24 | 1,67 | 0,00% | 257 899 |
19-04-24 | 1,67 | -3,47% | 505 550 |
uitgestelde koers Nasdaq, 25 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,23% | 108 mln. | |
-2,26% | 103 mld. | |
+1,41% | 95,71 mld. | |
+0,64% | 22,02 mld. | |
-17,84% | 20,9 mld. | |
-9,12% | 17,85 mld. | |
-42,83% | 16,21 mld. | |
-17,63% | 15,52 mld. | |
+4,55% | 13,86 mld. | |
+32,11% | 12,04 mld. |